Revefenacin Completed Phase 2 Trials for Chronic Obstructive Pulmonary Disease (COPD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03064113Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT02109172A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT017044047 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
NCT02040792A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)